Alopecia: A Google Trends Analysis of the Past 5 Years (2018-2023)

November 2024 in “ Skin Appendage Disorders ”

Lidiya N Todorova, Nicolas Kluger

alopecia alopecia areata telogen effluvium androgenetic alopecia frontal fibrosing alopecia

TLDR Google trends show varying interest in alopecia types, but it's not a reliable health measure.

The study analyzed Google trends data from 2018 to 2023 to assess public interest in various alopecia-related diagnoses. It found that search volumes for "alopecia" and "alopecia areata" remained stable, while "telogen effluvium" saw increased searches during 2020-2022. Interest in "androgenetic alopecia" and "frontal fibrosing alopecia" has grown over the past 5 years. Geographic differences were noted, with Middle Eastern countries showing more interest in alopecia areata, Latin American and Spanish-speaking countries in telogen effluvium, and Western countries in frontal fibrosing alopecia. The study concludes that while Google trends can provide insights into public interest, it is not a true epidemiological tool, as it only reflects searches by individuals with internet access and does not indicate the reasons behind the searches.

View this study on doi.org →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Diffuse hair loss and scalp biopsies

in Research 692 upvotes 4 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community How essential is scalp biopsy when dealing with hair loss?

in Treatment 6 upvotes 2 months ago

The user experienced hair loss despite using Fin and Min for 12 years and switched to Dutasteride, RU58841, and Keto scalp serum, but shedding and itch persist. They are considering increasing Dutasteride to 2.5mg and questioning the necessity of a scalp biopsy, with mixed opinions on its usefulness.

community HLT Megathread on HMI-115 (key takeaways in comments)

in Research/Science 39 upvotes 1 year ago

HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

community ~3.5 Months on daily oral dut 0.5mg, oral min 2.5mg, topical RU 80mg, weekly microneedling at 1.5mm

in Progress Pictures 34 upvotes 1 year ago

The conversation is about a 23-year-old who started treating their hair loss with daily oral dutasteride (0.5mg), oral minoxidil (2.5mg), topical RU58841 (80mg), and weekly microneedling at 1.5mm after seeing others' success stories. Significant improvements have been noted, and there is optimism for even better results in the next 6 months.

community I am a dermatologist with a clinical interest in alopecia. AMA

in Will treatment work for me? 2 years ago

In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

community Dermatologist tells me I don't have any serious signs of hair loss. This is my hairline.

in Chat 30 upvotes 1 year ago

A user is confused about a dermatologist's positive assessment of their scalp despite concerns about their hairline. They discuss using oral minoxidil, concerns about side effects from finasteride, and difficulty finding topical finasteride.

Similar Research

6 / 1000+ results

research Primary Scalp Alopecia: New Histopathological Tools, New Concepts, and a Practical Guide to Diagnosis

14 citations, September 2016 in “Journal of Cutaneous Pathology”

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Primary Scarring Alopecias: Review of Histopathological Findings of 37 Patients from the Department of Dermatology at the Hospital das Clínicas, Faculty of Medicine, University of São Paulo from 2000 to 2005

research Primary Scarring Alopecias: Review of Histopathological Findings of 37 Patients from the Department of Dermatology at the Hospital das Clínicas, Faculty of Medicine, University of São Paulo from 2000 to 2005

January 2011

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

research Primary Cicatricial Alopecia: Treatment Approaches and Classification

95 citations, November 2016 in “Journal of The American Academy of Dermatology”

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

research Histopathologic Evaluation of Alopecias

90 citations, June 2006 in “The American Journal of Dermatopathology”

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

research Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study

56 citations, January 2019 in “Skin appendage disorders”

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

research Hair and Scalp Dermatoscopy (Trichoscopy)

2 citations, July 2018 in “Elsevier eBooks”

Trichoscopy is a useful tool for diagnosing and managing hair and scalp conditions, often better than traditional methods.